Ken Fisher Ultragenyx Pharmaceutical Inc. Transaction History

Fisher Asset Management, LLC

$271 Billion
Q3 2025

A detailed history of Ken Fisher (Fisher Asset Management, LLC) transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Fisher Asset Management, LLC holds 168,084 shares of RARE stock, worth $5.56 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

168,084

Previous 185,756 9.51%

Holding current value

$5.56 Million

Previous $6.75 Million 25.16%

% of portfolio

0.0%

Previous 0.0%

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 12, 2025	SELL	$26.31 - $41.44 $464,950 - $732,327	-17,672 Reduced 9.51%	168,084 $5.06 Million
Q2 2025 Aug 13, 2025	SELL	$31.06 - $39.3 $683,288 - $864,560	-21,999 Reduced 10.59%	185,756 $6.75 Million
Q1 2025 May 14, 2025	SELL	$36.21 - $45.78 $2.08 Million - $2.63 Million	-57,434 Reduced 21.66%	207,755 $7.52 Million
Q4 2024 Feb 05, 2025	BUY	$42.07 - $57.72 $11.2 Million - $15.3 Million	265,189 New	265,189 $11.2 Million

About Ultragenyx Pharmaceutical Inc.

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $2.32B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

More about RARE

Track Ken Fisher's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fisher Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fisher Asset Management, LLC and Ken Fisher with notifications on news.

Account